DK1171124T3 - Anthelmintpræparater - Google Patents

Anthelmintpræparater

Info

Publication number: DK1171124T3
Authority: DK; Denmark
Prior art keywords: anthelmint; preparations; triclabendazole; formulation; mixing
Prior art date: 1999-04-14

Application number

DK00917514T

Other languages

English (en)

Other versions

DK1171124T4 (da

Inventor

Manson Harvey Colin

Original Assignee

Merial Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-14

Filing date

2000-04-14

Publication date

2008-06-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19927212&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1171124(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-04-14 Application filed by Merial Ltd filed Critical Merial Ltd

2008-06-16 Publication of DK1171124T3 publication Critical patent/DK1171124T3/da

2011-02-07 Application granted granted Critical

2011-02-07 Publication of DK1171124T4 publication Critical patent/DK1171124T4/da

Links

238000002360 preparation method Methods 0.000 title 1
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 3
NQPDXQQQCQDHHW-UHFFFAOYSA-N 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzimidazole Chemical compound ClC=1C=C2NC(SC)=NC2=CC=1OC1=CC=CC(Cl)=C1Cl NQPDXQQQCQDHHW-UHFFFAOYSA-N 0.000 abstract 2
238000009472 formulation Methods 0.000 abstract 2
229960000323 triclabendazole Drugs 0.000 abstract 2
OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 abstract 1
IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 abstract 1
239000005660 Abamectin Substances 0.000 abstract 1
229920001030 Polyethylene Glycol 4000 Polymers 0.000 abstract 1
229950008167 abamectin Drugs 0.000 abstract 1
230000000507 anthelmentic effect Effects 0.000 abstract 1
235000019445 benzyl alcohol Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Tropical Medicine & Parasitology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Compounds Of Unknown Constitution (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

DK00917514.2T 1999-04-14 2000-04-14 Anthelmintpræparater DK1171124T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NZ335166A NZ335166A (en)	1999-04-14	1999-04-14	Anthelmintic composition containing triclabendazole in at least one solvent
PCT/NZ2000/000053 WO2000061068A2 (en)	1999-04-14	2000-04-14	Anthelmintic compositions

Publications (2)

Publication Number	Publication Date
DK1171124T3 true DK1171124T3 (da)	2008-06-16
DK1171124T4 DK1171124T4 (da)	2011-02-07

Family

ID=19927212

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00917514.2T DK1171124T4 (da)	1999-04-14	2000-04-14	Anthelmintpræparater

Country Status (16)

Country	Link
US (1)	US7638545B1 (da)
EP (1)	EP1171124B2 (da)
AT (1)	ATE386516T1 (da)
AU (1)	AU760791B2 (da)
CA (1)	CA2364742C (da)
CY (1)	CY1107446T1 (da)
DE (1)	DE60038106T3 (da)
DK (1)	DK1171124T4 (da)
ES (1)	ES2302691T5 (da)
HU (1)	HU225620B1 (da)
NZ (1)	NZ335166A (da)
PT (1)	PT1171124E (da)
SI (1)	SI1171124T2 (da)
SK (1)	SK286363B6 (da)
WO (1)	WO2000061068A2 (da)
ZA (1)	ZA200108323B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU733095B3 (en) *	1999-09-22	2001-05-03	Ashmont Holdings Limited	Sheep pour on
US8067382B2 (en) *	2002-01-08	2011-11-29	Merial Limited	Anthelmintic composition
CN1435176A (zh) *	2002-01-29	2003-08-13	王玉万	以表面活性剂为基础的含三氯苯哒唑的新制剂
GB2386066A (en)	2002-02-28	2003-09-10	Norbrook Lab Ltd	Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
AU2002952597A0 (en) *	2002-11-11	2002-11-28	Schering-Plough Pty. Limited	Topical parasiticide formulations and methods of treatment
GB2403408B (en) *	2003-07-03	2007-09-19	Michael Hilary Burke	Process for preparing a stable anthelmintic suspension formulation
GB0316377D0 (en)	2003-07-12	2003-08-13	Norbrook Lab Ltd	Parasiticidal composition
WO2005074914A1 (en) *	2004-02-03	2005-08-18	Wyeth	Anthelmintic composition
ATE515264T1 (de) *	2005-09-15	2011-07-15	Merial Ltd	Anthelmintische formulierungen
BRPI0506279B1 (pt)	2005-12-16	2018-01-09	Npa - Núcleo De Pesquisas Aplicadas Ltda	Composição sinergística de antihelmínticos e endectocidas
NZ552040A (en) *	2006-12-13	2009-04-30	Bomac Research Ltd	Veterinary formulation comprising an anthelmintic compound and glyceryl acetate
BRPI0819849B8 (pt) *	2007-11-26	2021-05-25	Merial Ltd	sistemas de solvente para formulações pour on para combater parasitas
AU2013201461B2 (en) *	2007-11-26	2015-10-29	Boehringer Ingelheim Animal Health USA Inc.	Solvent systems for pour-on formulations for combating parasites
RU2493825C2 (ru)	2008-10-08	2013-09-27	ВАЙЕТ ЭлЭлСи	Бензимидазольные антигельминтные композиции
AR081970A1 (es)	2010-06-24	2012-10-31	Intervet Int Bv	Formulacion inyectable de una lactona macrociclica y levamisol, formulacion y uso veterinario
AU2011338573B2 (en)	2010-12-07	2016-07-28	Boehringer Ingelheim Animal Health USA Inc.	Topical combination formulations of macrocyclic lactones with synthetic pyrethroids
JP2025516701A (ja) *	2022-05-19	2025-05-30	ダウグローバルテクノロジーズエルエルシー	Ｂｃｓクラスｉｉの薬物の改良された可溶化のためのｐｅｇベースのインターポリマー錯体の使用
KR102981906B1 (ko)	2024-09-13	2026-06-24	경희대학교 산학협력단	이버멕틴을 포함하는 클로노르키스 시넨시스에 대한 구충제 조성물

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2614841A1 (de) †	1976-04-06	1977-10-20	Bayer Ag	Neue pour-on-formulierungen von anthelmintika
US4197307A (en)	1977-04-12	1980-04-08	Ciba-Geigy Corporation	2-Alkylthio-, 2-alkylsulphinyl- and 2-alkylsulfonyl-6-phenylbenzimidazoles as anthelmintic agents
US4144352A (en) *	1977-12-19	1979-03-13	Merck & Co., Inc.	Milbemycin compounds as anthelmintic agents
NZ197796A (en)	1980-08-04	1984-11-09	Merck & Co Inc	Stabilised aqueous formulations containing ivermectin
JPS57139012A (en)	1981-02-23	1982-08-27	Sankyo Co Ltd	Anthelmintic composition
ZA831793B (en) *	1982-03-16	1983-11-30	Wellcome Australia	Pour-on formulation
NZ208992A (en)	1983-08-12	1987-03-06	Ici Australia Ltd	Endoparasiticidal compositions for topical administration,containing ether or glycol carboxylate ester
AU563927B2 (en)	1983-08-12	1987-07-30	Pitman-Moore Australia Limited	Compositions
AU3135884A (en)	1983-08-22	1985-02-28	Ici Australia Limited	Endoparasiticides with ketone carriers
NZ209100A (en) *	1983-08-22	1987-01-23	Ici Australia Ltd	Topical compositions for control of endoparasites
NZ210505A (en)	1983-12-22	1988-06-30	Merck & Co Inc	Parasiticidal compositions containing avermectin or milbemycin derivatives
US5169846A (en)	1989-10-12	1992-12-08	Crooks Michael J	Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
GB9115273D0 (en)	1991-07-15	1991-08-28	Pfizer Ltd	Benzimidazole anthelmintics
GB9205368D0 (en) †	1992-03-12	1992-04-22	Pfizer Ltd	Benzimidozole anthelmintic agents
GB9302107D0 (en) *	1993-02-03	1993-03-24	Univ Court Of The University O	Benzimidazole compositions
WO1994027598A1 (en)	1993-05-26	1994-12-08	Commonwealth Scientific And Industrial Research Organisation	Antiparasitic compositions
NZ260018A (en) †	1994-03-03	1995-10-26	Bomac Lab Ltd	Benzimidazole compositions and anthelmintic compositions
DE69636706T2 (de) *	1995-09-25	2007-10-11	Ashmont Holdings Ltd., Takapuna	Makrocyclische lacton anthelmintika
US5861142A (en) *	1996-03-25	1999-01-19	Schick; Mary Pichler	Method for promoting hair, nail, and skin keratinization
WO1998006407A1 (en) *	1996-07-30	1998-02-19	Ashmont Holdings Limited	Anthelmintic formulations
FR2755824B1 (fr) †	1996-11-19	1999-01-08	Virbac Sa	Formulation galenique des benzimidazoles a usage topique, son procede de preparation et ses utilisations
US6054140A (en)	1997-03-21	2000-04-25	Biogenesis S.A.	Long acting injectable parasiticidal composition and the process for its preparation
NZ329247A (en)	1997-11-20	2000-08-25	Bomac Lab Ltd	Anthelmintic compositions containing solubilised benzimidazoles such as oxfendazole and a carrier including a pyrrolidone
US6340672B1 (en) *	2000-02-16	2002-01-22	Phoenix Scientific, Inc.	Parasiticidal formulation and a method of making this formulation

1999
- 1999-04-14 NZ NZ335166A patent/NZ335166A/en not_active Application Discontinuation
2000
- 2000-04-14 ES ES00917514T patent/ES2302691T5/es not_active Expired - Lifetime
- 2000-04-14 CA CA2364742A patent/CA2364742C/en not_active Expired - Lifetime
- 2000-04-14 SK SK1420-2001A patent/SK286363B6/sk not_active IP Right Cessation
- 2000-04-14 WO PCT/NZ2000/000053 patent/WO2000061068A2/en not_active Ceased
- 2000-04-14 SI SI200030991T patent/SI1171124T2/sl unknown
- 2000-04-14 DK DK00917514.2T patent/DK1171124T4/da active
- 2000-04-14 EP EP00917514A patent/EP1171124B2/en not_active Expired - Lifetime
- 2000-04-14 PT PT00917514T patent/PT1171124E/pt unknown
- 2000-04-14 DE DE60038106T patent/DE60038106T3/de not_active Expired - Lifetime
- 2000-04-14 AT AT00917514T patent/ATE386516T1/de active
- 2000-04-14 US US09/958,814 patent/US7638545B1/en not_active Expired - Fee Related
- 2000-04-14 HU HU0200735A patent/HU225620B1/hu unknown
- 2000-04-14 AU AU38474/00A patent/AU760791B2/en not_active Expired
2001
- 2001-10-10 ZA ZA2001/08323A patent/ZA200108323B/en unknown
2008
- 2008-04-30 CY CY20081100463T patent/CY1107446T1/el unknown

Also Published As

Publication number	Publication date
CA2364742A1 (en)	2000-10-19
CY1107446T1 (el)	2012-12-19
EP1171124B2 (en)	2010-10-27
ES2302691T3 (es)	2008-08-01
DE60038106D1 (de)	2008-04-03
WO2000061068A3 (en)	2001-01-11
AU760791C (en)	2000-11-14
EP1171124A2 (en)	2002-01-16
HUP0200735A2 (hu)	2002-07-29
AU3847400A (en)	2000-11-14
NZ335166A (en)	2001-11-30
DE60038106T3 (de)	2011-06-01
HUP0200735A3 (en)	2004-03-29
ZA200108323B (en)	2002-06-26
SK14202001A3 (sk)	2002-05-09
WO2000061068A2 (en)	2000-10-19
US7638545B1 (en)	2009-12-29
SI1171124T1 (sl)	2008-08-31
PT1171124E (pt)	2008-04-18
EP1171124A4 (en)	2004-05-12
ES2302691T5 (es)	2011-03-16
HU225620B1 (en)	2007-05-02
SK286363B6 (sk)	2008-08-05
EP1171124B1 (en)	2008-02-20
CA2364742C (en)	2010-03-23
ATE386516T1 (de)	2008-03-15
DE60038106T2 (de)	2009-01-29
DK1171124T4 (da)	2011-02-07
AU760791B2 (en)	2003-05-22
SI1171124T2 (sl)	2011-02-28

Publication	Publication Date	Title
DK1171124T4 (da)	2011-02-07	Anthelmintpræparater
DK1299348T3 (da)	2008-07-28	Forbindelser og sammensætninger til levering af aktive midler
AR039688A1 (es)	2005-03-09	Preparaciones acidas de insulina con estabilidad mejorada
DK1187601T3 (da)	2005-11-21	Hidtil ukendt præparat og administrationsform som omfatter en syrelabil protonpumpeinhibitor
BR0313343A (pt)	2005-07-12	Uso de uma mistura de agentes permeantes, soluções para aplicação ungueal e periungueal e uso de uma solução para aplicação ungueal e periungueal
BRPI0409185A (pt)	2006-04-11	formulações veterinárias anti-helmìnticas tópicas
DK1345611T3 (da)	2011-03-14	Antibiotisk/analgetisk formulering og en fremgangsmåde til fremstilling deraf
WO2003018059A3 (de)	2003-11-13	Kombinationspräparate von arylsubstituierten propanolaminderivaten mit weiteren wirkstoffen und deren verwendung
DE60105448D1 (de)	2004-10-14	Feste dispersionen mit nitrataktiven wirkstoffen
DK1280558T3 (da)	2005-12-27	Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
WO2003066597A3 (en)	2004-04-01	Guanidino compounds
DE60142913D1 (de)	2010-10-07	Arzneilösungen enthaltend modafinilverbindungen
ES2157886T3 (es)	2001-09-01	Composiciones tensioactivas y procedimientos.
EA200702594A1 (ru)	2008-04-28	Многофункциональные композиции концентрата с высоким содержанием действующего вещества для контроля эктопаразитов
ATE454136T1 (de)	2010-01-15	Therapeutische zusammensetzungen zur pulmonalen verabreichung
UY28622A1 (es)	2005-06-30	Agentes antibacterianos de quinolona
BR0012735A (pt)	2005-02-22	Preparação solida, e, processo para produzir preparações
PT1179979E (pt)	2003-06-30	Misturas de agentes tensioactivos utilizados como agentes humectantes e/ou emulsificantes em preparacoes agroquimicas
DE50114127D1 (de)	2008-08-28	Torasemid enthaltende lagerstabile pharmazeutische zubereitungen
GEP20063861B (en)	2006-06-26	Injection solution comprising lhrh antagonist
HRP20050342B1 (hr)	2013-11-08	Farmaceutska formulacija olanzapina
PT1200088E (pt)	2003-10-31	Composicao contendo paracetamol e drotaverina
AR057648A1 (es)	2007-12-12	Composicion de metaflumizona para la administracion topica
ES8102803A1 (es)	1981-02-16	Procedimiento para la preparacion de cuerpos microporosos que engloben uno o mas agentes activos
ATE315041T1 (de)	2006-02-15	Salz von morphin-6-glucuronid